Access in Dubai, UAE

Middle East ยท Tier 1

Regulatory framework

Dubai runs the emirate-level Named Patient / compassionate-use pathway through Dubai Health Authority (DHA), coordinated with the federal Ministry of Health and Prevention (MoHAP) where required. Dubai-licensed physicians apply on behalf of individual patients for drugs not registered in-country or not stocked at the dispensing facility. Tertiary hospitals such as American Hospital Dubai, Mediclinic City Hospital, and King's College Hospital London Dubai use this workflow routinely.

Case active and ready to skip the regulatory walkthrough? Start your case or WhatsApp us.

Typical timeline

For patients in Dubai requesting a specialty drug through Reserve Meds, the end-to-end timeline from initial request to drug delivery typically ranges 2-8 weeks. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

  1. Patient or physician submits a request with drug name and indication.
  2. We verify clinical appropriateness and document eligibility.
  3. Treating physician issues prescription and clinical justification.
  4. Country-specific regulatory documentation is prepared and submitted.
  5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
  6. Drug ships cold-chain to destination physician or hospital pharmacy.
  7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from Dubai

Lenmeldy

Metachromatic leukodystrophy

Kresladi

Leukocyte adhesion deficiency I

Elevidys

Duchenne muscular dystrophy

Lyfgenia

Sickle cell disease

Zevaskyn

Recessive DEB

Skysona

Cerebral adrenoleukodystrophy

Casgevy

Sickle cell disease; transfusion-dependent beta-thalassemia

Ryoncil

Pediatric SR-aGvHD

Tecelra

Synovial sarcoma

Encelto

Macular telangiectasia type 2

Qfitlia

Hemophilia A/B prophylaxis

Vyjuvek

Dystrophic epidermolysis bullosa

WhatsApp